Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Dexmedetomidine on Intravenous Anesthetic Requirements for Children Undergoing Dental Procedures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* ASA 1-2~* Elective dental surgery~* Planned general anesthesia with TIVA~* Age 2-10 years~Exclusion Criteria:~* General anesthesia with inhalation induction~* Documented seizure disorder~* Cardiac disease~* Cardiac rhythm abnormalities~* Chronic hypertension~* Weight \< 5th centile or \> 95th centile for age~* Pre-operative administration of anxiolytics (such as benzodiazepines or opioid analgesics)~* Hypersensitivity to dexmedetomidine or any other study medication

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 10 Years
- Healthy Volunteers: f

Study Arms:
- Saline bolus (Type: SHAM_COMPARATOR): 10mL normal saline solution administered intravenously over 60 seconds starting after intubation.
- Dexmedetomidine 0.25 mcg/kg (Type: EXPERIMENTAL): 0.25 mcg/kg dexmedetomidine diluted with normal saline to a 10mL volume, administered intravenously over 60 seconds starting after intubation.
- Dexmedetomidine 0.50 mcg/kg (Type: EXPERIMENTAL): 0.50 mcg/kg dexmedetomidine diluted with normal saline to a 10mL volume, administered intravenously over 60 seconds starting after intubation.
- Dexmedetomidine 1.00 mcg/kg (Type: EXPERIMENTAL): 1.00 mcg/kg dexmedetomidine diluted with normal saline to a 10mL volume, administered intravenously over 60 seconds starting after intubation.

Based on this trial design, predict the completion outcome and termination type (if applicable).